Ibogain och litteratur

Tillbaka hem 

 

Ibogain Litteratur

 

Bibliografi per: 97-11-21

OBS! Inga av länkarna nedan fungerar för hemladdning av pdf:er. Pröva http://www.puzzlepiece.org/ibogaine/literature/iborefs.html

 

Aaron, J. J.; Sanders, L. B. and Winefordner, J. D. "Analytical study of some
important hallucinogens by a combined fluorimetric and phosphorimetric method.",
Clinica Chimica Acta, (1973), 45(4), 375-386.

Abaul, J.; Philogene, E.; Bourgeois, P.; Ahond, A.; Poupat, C. and Potier, P.
"Contributions to a study of American Tabernaemontanae. VI. Alkaloids from the
leaves of Tabernaemontana citrifolia.", Journal of Natural Products, (1989),
52(6), 1279-1283 (French). PDF (596 KB)

Abraham, H. D.; Aldridge, A. M. and Gogia, P. "The psychopharmacology of
hallucinogens.", Neuropsychopharmacology, (1996), 14, 285-298.

Aceto, M. D.; Bowman, E. R.; Harris, L. S. and May, E. L. "Dependence studies
of new compounds in the rhesus monkey and mouse (1991).", NIDA Research
Monograph, (1992), 119, 513-558. PDF (391 KB)

Aceto, M. D.; Bowman, E. R.; Harris, L. S. and May, E. L. "Dependence studies
on new compounds in the rhesus monkey, rat and mouse (1989).", NIDA Research
Monograph, (1989), 95, 578-631. PDF (2.9 MB)

Achenbach, Hans and Raffelsberger, Bernd. "Alkaloids in Tabernaemontana
species, XI. Investigation of the alkaloids from Tabernaemontana quadrangularis
- (20R)-20-hydroxyibogamine, a new alkaloid from T. quadrangularis.",
Zeitschrift fur Naturforschung. Teil B: Anorganische Chemie, Organische Chemie,
(1980), 35B(2), 219-225 (German). PDF (984 KB)

Achenbach, Hans and Raffelsberger, Bernd. "Alkaloids in Tabernaemontana
species, XII. Investigation of the alkaloids from Tabernaemontana olivacea -
condylocarpine-N-oxide, a new alkaloid from T. olivacea.", Zeitschrift fur
Naturforschung. Teil B: Anorganische Chemie, Organische Chemie, (1980), 35B(7),
885-891 (German). PDF (902 KB)

Adams, Jan Thatcher. "Drug ibogaine offers relief to addicts.", The Edge,
(May 1995), 22.

Ahmad, Yusuf; Le Quesne, P. W. and Neuss, N. "The structure of sewarine, an
indole alkaloid from Rhazya stricta.", Journal of the Chemical Society. D,
Chemical Communications, (1970), 9, 538-539. PDF
(258 KB)

Alburges, M. E.; Foltz, R. L. and Moody, D. E. "Determination of ibogaine and
12-hydroxyibogamine in plasma by gas chromatography positive ion chemical
ionization mass spectrometry.", Journal of Analytical Toxicology, (October
1995), 19(6), 381-386.

Ali, S. F.; Newport, G. D.; Slikker, W. Jr.; Rothman, R. B. and Baumann, M.
H. "Neuroendocrine and neurochemical effects of acute ibogaine administration -
a time course evaluation.", Brain Research, (1996), 737(1-2), 215-220.

Ali, S. F.; Chetty, S. C.; Meng, X. M.; Newport, G. D. and Slikker, W. "A
single injection of ibogaine produces selective neurochemical changes in mouse
brain.", Journal of Neurochemistry, (1995), 65, S172. PDF (164 KB)

Allen, M. J. and Powell, V. J. "Anodic polarography with a rotating platinum
microelectrode. II. Oxidation of various indole alkaloids.", Journal of the
Electrochemical Society, (1958), 105, 541-544.

Annonymous. PharmChem Newsletter, (1972), 1(2), 3-4.

Anonymous. "Conditions for investigational use of hallucinogenic drugs
bufotenine, N,N-diethyltryptamine, and ibogaine and their salts.", Federal
Register, (January 31, 1968), 33, 2384.

Anonymous. "Depressant and stimulant drugs. Listing of additional drugs as
drugs subject to control.", Federal Register, (September 23, 1967), 32,
13407-13408.

Arai, Gerda; Coppola, J. and Jeffrey, G. A. "The structure of ibogaine.",
Acta Crystallographica, (1960), 13, 553-564.

Aries, Robert. "Doping control in race horses.", Belgian patent, (September
16, 1965), 664,377.

Atta-ur-Rahman; Fatima, T.; Crank, George and Wasti, Shaheen. "Alkaloids from
Trachelospermum jasminoides.", Planta Medica, (1988), 54(4), 364. PDF (129 KB)

Augustine, R. L. "Synthesis of iboga alkaloids and related compounds.",
Psychopharmacology Bulletin, (April 1969), 5(2), 18.

Badio, Barbara; Padgett, William L. and Daly, John W. "Ibogaine: A potent
noncompetitive blocker of ganglionic/neuronal nicotinic receptors.", Molecular
Pharmacology, (1997), 51(1), 1-5. PDF (608 KB)

Bagal, A. A.; Hough, L. B.; Nalwalk, J. W. and Glick, S. D. "Modulation of
morphine-induced antinociception by ibogaine and noribogaine.", Brain Research,
(1996), 741(1-2), 258-262.

Bartlett, M. F.; Dickel, D. F. and Taylor, W. I. "The structures of
ibogamine, ibogaine, tabernanthine, and voacangine.", Journal of the American
Chemical Society, (1958), 80, 126-136.

Barrass, B. C. and Coult, D. B. "Interaction of some centrally active drugs
with ceruloplasmin.", Biochemical Pharmacology, (1972), 21(5), 677-685

Barrass, B. C. and Coult, D. B. "Effects of some centrally acting drugs on
ceruloplasmin.", Progress in Brain Research, (1972), 36, 97-104.

Batchily, F.; Mehri, H. and Plat, M. "Alkaloids from the seeds of
Sarcopharyngia crassa (Benth.) Boiteau et Allorge.", Annales Pharmaceutiques
Francaises, (1986), 44(6), 449-454 (French).

Benwell, Maureen E. M.; Holtom, Pamela E.; Moran, Robert J. and Balfour,
David J. K. "Neurochemical and behavioural interactions between ibogaine and
nicotine in the rat.", British Journal of Pharmacology, (February 1996), 117(4),
743-749. PDF (896 KB)

Bert, M. et al. "Alkaloids of Pagiantha cerifera.", Fitoterapia, (1989),
60(2), 141-146.

Bert, Maryse; Marcy, Rene; Quermonne, Marie-Anne; Cotelle, Michel and Koch,
Michel "Non-amphetaminic central stimulation by alkaloids from the ibogaine and
vobasine series.", Planta Medica, (June 1988), 54(3), 191-192. PDF (256 KB)

Bertol, Elisabetta; Mari, Francesco and Froldi, Rino "[Detection of ibogaine
in organic liquids.]", Journal of Chromatography, (February 4, 1976), 117(1),
239-241 (French). PDF (362 KB)

Bhargava, H. N.; Cao, Y. J. and Zhao, G. M. "Effects of ibogaine and
noribogaine on the antinociceptive action of mu-, delta- and kappa-opioid
receptor agonists in mice.", Brain Research, (March 28, 1997), 752(1-2),
234-238.

Biemann, K. and Friedmann-Spiteller, Margot. "Application of mass
spectrometry to structure problems. V. Iboga alkaloids.", Journal of the
American Chemical Society, (1961), 83, 4805-4810.

Biemann, K. and Friedmann-Spiteller, Margot. "Mass spectrometric evidence for
the structure of iboxygaine and its tosylate.", Tetrahedron Letters, (1961), 2,
68-71.

Biemann, K. "Determination of the carbon skeleton of sarpagine by mass
spectrometry.", Tetrahedron Letters, (1960), 15, 9-14.

Blaha, K.; Koblicova, Z. and Trojanek, J. "Alkaloids. XXX. Chiroptical
investigations on the iboga and voacanga alkaloids.", Collection of Czechoslovak
Chemical Communications, (1974), 39(8), 2258-2266.

Blaha, K.; Koblicova, Z. and Trojanek, J. "Absolute configuration of the
Iboga and Voacanga alkaloids. Chiroptical approach.", Tetrahedron Letters,
(1972), 27, 2763-2766.

Blakeslee, Sandra. "Bizarre drug holds hope for addicts.", New York Times,
(Wednesday, October 27, 1993), v143:B7(N), pC11(L).

Bocher, Dominique and Naranjo, Claudio. "Psychopharmaceuticals.", German
patent, (September 4, 1969), 1,902,227 (German).

Bowen, W. D.; Vilner, B. J.; Williams, W.; Bertha, C. M.; Kuehne, M. E. and
Jacobson, A. E. "Ibogaine and its congeners are sigma(2) receptor-selective
ligands with moderate affinity.", European Journal of Pharmacology, (June 6,
1995), 279(1), R1-R3.

Brailowsky, Simon; Walter, Stephane; Vuillon-Cacciuttolo, Ghislaine and
Serbanescu, Tudor. "[Tremorogenic and nontremorogenic indole alkaloids: effects
on photosensitive epilepsy in Papio papio.]", Comptes Rendus des Seances de la
Societe de Biologie et de Ses Filiales, (Volume date 1975), 169(5), 1190-1193
(French).

Broderick, Patricia A.; Phelan, Frank T.; Eng, Frank and Wechsler, Robert T.
"Ibogaine modulates cocaine responses which are altered due to environmental
habituation: in vivo microvoltammetric and behavioral studies.", Pharmacology
Biochemistry and Behavior, (1994), 49(3), 711-728. PDF (2.6 MB)

Broderick, P. A.; Phelan, F. T. and Berger, S. P. "Ibogaine alters cocaine
induced biogenic amine and psychostimulant dysfunction but not [3H] GBR-12935
binding to the dopamine transporter protein", NIDA Research Monograph, (1992),
119, 285.

Bruneton, J.; Bouquet, A. and Cave, A. "Alkaloids from Daturicarpa elliptica
Stapf.", Plant Medicine and Phytotherapy, (1976), 10(1), 20-23 (French).

Brustier, Vincent; Vincent, Daniel and Sero, Irene. "The ultraviolet
absorption spectrum of ibogaine.", Comptes Rendus, (1943), 216, 909-911.

Buchi, G.; Coffen, D. L.; Kocsis, Karoly; Sonnet, P. E. and Ziegler,
Frederick E. "The total synthesis of Iboga alkaloids.", Journal of the American
Chemical Society, (1966), 88(13), 3099-3109. PDF
(2.1 MB)

Buchi, G. and Manning, R. E. "Chemical transformations of ibogaine.", Journal
of the American Chemical Society, (1966), 88(11), 2532-2535. PDF (703 KB)

Bunag, Ruben D. and Walaszek, E. J. "Cardiovascular-effects of substance P in
the chicken.", Annals of the New York Academy of Sciences, (1963), 104 (Article
1), 437-448.

Cao, Y. J. and Bhargava, H. N. "Effects of ibogaine on the development of
tolerance to antinociceptive action of mu-, delta- and kappa-opioid receptor
agonists in mice.", Brain Research, (March 28, 1997), 752(1-2), 250-254.

Cappendijk, S. L. T.; Fekkes, D. and Dzoljic, M. R. "Norharman - endogenous
inhibitor of morphine withdrawal.", Regulatory Peptides, (1994), 54(1), 39-40.
PDF (333 KB)

Cappendijk, Susanne L. T.; Fekkes, Durk and Dzoljic, Michailo R. "The
inhibitory effect of norharman on morphine withdrawal syndrome in rats:
comparison with ibogaine.", Behavioural Brain Research, (1994), 65, 117-119. PDF (377 KB)

Cappendijk, S. L. T. and Dzoljic, M. R. "Inhibitory effects of ibogaine on
cocaine self-administration in rats.", European Journal of Pharmacology, (1993),
241, 261-265.

Cartoni, G. Paolo and Giarusso, Alberto "Gas chromatographic determination of
ibogaine in biological fluids.", Journal of Chromatography, (August 23, 1972),
71(1), 154-158. PDF (611 KB)

Cavallaro, Aldo and Elli, Giuseppe. "Thin-layer electrophoresis of
hallucinogenic substances.", Bollettino dei Laboratori Chimici Provinciali,
(1972), 23(1), 27-32 (Italian).

Chen, K.; Kokate, T. G.; Donevan, S. D.; Carroll, F. I. and Rogawski, M. A.
"Ibogaine block of the NMDA receptor - in vitro and in vivo studies.",
Neuropharmacology, (1996), 35(4), 423-431.

Chen, Graham and Bohner, Barbara. "A study of central nervous system
stimulants.", Journal of Pharmacology and Experimental Therapeutics, (1958),
123(3), 212-215.

Clivio, Pascale; Richard, Bernard; Deverre, Jean-Robert; Sevenet, Thierry;
Zeches, Monique and Le Men-Oliver, Louisette. "Alkaloids from leaves and root
bark of Ervatamia hirta.", Phytochemistry, (1991), 30(11), 3785-3792. PDF (1.3 MB)

Codd, Ellen E. "High affinity ibogaine binding to a MU opioid agonist site.",
Life Sciences, (October 6, 1995), 57(20), PL315-PL320.

Cordier, P. "Generalities on the structure of azepine compounds used in drug
therapy.", Bulletin de la Societe de Pharmacie de Strasbourg, (1971), 14(1),
9-23 (French).

Cowley, Geoffrey. "A psychedelic trip to the end of addiction. (Health: Can a
tribal potion block cravings?)", Newsweek, (August 23, 1993), 122(8), 45.

Dagnino, Denise; Schripsema, Jan; Peltenburg, Anja; Verpoorte, Robert and
Teunis, Kees. "Capillary gas chromatographic analysis of indole alkaloids:
investigation of the indole alkaloids present in Tabernaemontana divaricata cell
suspension culture.", Journal of Natural Products, (1991), 54(6), 1558-1563. PDF (870 KB)

Damak, Mohamed; Poupat, Christiane and Ahond, Alain.
"Bis-12-[11-hydroxycoronaridinyl], a new dimeric alkaloid of the ibogane type.
Structure elucidation by carbon-13 NMR.", Tetrahedron Letters, (1976), 39,
3531-3534 (French).

De Rienzo, Paul; Beal, Dana and others. "The Ibogaine Story, Report on the
Staten Island Project.", Autonomedia: POB 568 Williamsburgh Station, Brooklyn,
New York 11211-0568 USA, (1997), 352 p.

De Zorzi, Claudio and Cutrona, Carolina. "Hallucinogenic drugs.
Chemicopharmacological, social, and juridical aspects.", Zacchia, (1973), 8(3),
359-434 (Italian).

Deecher, Darlene C.; Teitler, Milton; Soderlund, David M.; Bornmann, William
G.; Kuehne, Martin E. and Glick, Stanley D. "Mechanisms of action of ibogaine
and harmaline congeners based on radioligand binding studies.", Brain Research,
(1992), 571, 242-247. PDF (677 KB)

Delourme-Houde, M. Jean. "Study of iboga (Tabernanthe iboga H. Bn.).",
Annales Pharmaceutiques Francaises, (1946), 4, 30-36 (French). PDF (846 KB)

Denolin-Dewaersegger, L. and van Binst, G. "Effect of solvent on the O-H and
N-H stretching frequencies of some alcohols and amines.", Bulletin des Societes
Chimiques Belges, (1962), 71, 615-622.

Depoortere, H. "Neocortical rhythmic slow activity during wakefulness and
paradoxical sleep in rats.", Neuropsychobiology, (1987), 18, 160-168. PDF (1.5 MB)

Depoortere, H.; Leonardon, J. and Jalfre, M. "The influence of some
pharmacological agents on the duration of sodium .gamma.-hydroxybutyrate-induced
'sleep' in curarized rats.", Proceedings of the European Congress on Sleep
Research, 3rd, (Meeting Date 1976), 370-372.

Deus-Neumann, B.; Stoeckigt, J. and Zenk, M. H. "Radioimmunoassay for the
quantitative determination of catharanthine.", Planta Medica, (1987), 53(2),
184-188.

Dhahir, H. I.; Jain, Naresh C. and Thornton, John I. "The identification of
ibogaine in biological material.", Journal - Forensic Science Society, (January
1972), 12(1), 309-313. PDF (764 KB)

Dhahir, Hashim I. "Comparative study on the toxicity of ibogaine and
serotonin.", Dissertation Abstracts International. B, Science and Engineering.,
(1971), 32(4), 2311-2312.

Dhahir, H. I.; Jain, N. C. and Forney, R. B. "Methods for the detection and
determination of ibogaine in biological materials.", Journal of Forensic
Sciences, (January 1971), 16(1), 103-108. PDF (760
KB)

Diamond, Nina L. "Ibogaine II: down memory lane; Does one trip equal 30 years
on a therapist's couch?", Omni, (February 1994), 16(5), 16.

Dickel, D. F.; Holden, C. L.; Maxfield, R. C.; Paszek, L. E. and Taylor, W.
I. "The alkaloids of Tabernanthe iboga. Part III. Isolation studies.", Journal
of the American Chemical Society, (1958), 80, 123-125.

Doblin, Rick. "NIDA to Fund Ibogain Studies.", Psychedelic Illuminations,
volume 6, (1994?), 9-11.

Duc, Do Khac Manh and Fetizon, Marcel. "[Synthesis of ibogaine analogs.]",
Bulletin de la Societe Chimique de France, (1969), 11, 4154-4159 (French). PDF (898 KB)

Duc, Do Khac Manh and Fetizon, Marcel. "[Synthesis of an ibogaine analog.]",
Bulletin de la Societe Chimique de France, (1966), 2, 771-772 (French). PDF (302 KB)

Dworkin, Steven I.; Gleeson, Suzanne; Meloni, Domenico; Koves, Timothy R. and
Martin, Thomas J. "Effects of ibogaine on responding maintained by food, cocaine
and heroin reinforcement in rats.", Psychopharmacology, (February 1995), 117(3),
257-261. PDF (673 KB)

Dzoljic, E. D.; Kaplan, C. D. and Dzoljic, M. R. "Effect of ibogaine on
naloxone-precepitated withdrawal syndrome in chronic morphine-dependent rats.",
Archive of International Pharmacodynamics, (1988), 294, 64-70. PDF (687 KB)

Epstein, Joseph William and Goldman, Leon. "Acyl derivatives of
10-methoxyibogamine.", Unites States patent, (February 6, 1973), 3,715,361. PDF (337 KB)

Fares, Fares A. and Jankowski, Christopher K. "Gif(IV) oxidation of some
indolic alkaloids.", Heterocycles, (1992), 34(11), 2109-2115. PDF (724 KB)

Farnsworth, Norman R. "Hallucinogenic plants: various chemical substances are
known to be the active hallucinogenic principles in many plants.", Science,
(1968), 162, 1086-1092.

Fernandez, J. W. "Bwiti: An Ethnography of the Religious Imagination of
Africa.", Princeton University Press, Princeton, NJ, (1982).

Fernandez, J. W. "Tabernanthe iboga: Narcotic ecstasis and the work of the
ancestors", Flesh of the Gods: The Ritual Use of Hallucinogens, Furst, P. T. Ed:
Praeger, New York, (1972), 237-260.

Fiorese, F.; Vermuelen, G. and Turcotte, C. "Ferric chloride/hydrogen
chloride/potassium iodide versatile wide application reagent.", Substance and
Alcohol Actions/Misuse, (1982), 3(1-2), 47-59.

Fiorese, F.; Vermeulen, G. and Turcotte, C. "Ferric chloride/hydrogen
chloride/potassium chloride versatile wide application reagent.", Toxicological
Aspects, [International Congress of the European Association of Poison Control
Centers], (1980), 9th, 431-445.

Fonne-Pfister, Raymonde and Meyer, Urs A. "Xenobiotic and endobiotic
inhibitors of cytochrome P-450dbl function, the target of the
debrisoquine/sparteine type polymorphism.", Biochemical Pharmacology, (1988),
37(20), 3829-3835.

Fox, Nicols. "Iboga? Frog calls? It's community radio.", Washington
Journalism Review, (October 1991), 13(8), 15.

Frances, B.; Gout, R.; Cros, J. and Zajac, J. M. "Effects of ibogaine on
naloxone-precipitated withdrawal in morphine-dependent mice.", Fundamental &
Clinical Pharmacology, (1992), 6(8-9), 327-332.

French, E. D.; Dillon, K. and Ali, S. F. "Effects of ibogaine, and cocaine
and morphine after ibogaine, on ventral tegmental dopamine neurons.", Life
Sciences, (1996), 59(12), PL199-PL205.

Furst, P. T. "Los Alucinogenos y la Cultura." Fondo de Cultura Economica,
Mexico City (1980), (Spanish).

Furst, P. T. "Hallucinogens and Culture.", Chandler & Sharp, Novato, CA,
(1976).

Gaignault, J. C. and Delourme-Houde, J. "Les alcaloides de l'iboga.",
Fitoterapia, (1977), 48, 243-265 (French).

Gallagher, Carol A.; Hough, Lindsay B.; Keefner, Sandra M.; Seyed-Mozaffari,
Ahmad; Archer, Sydney and Glick, Stanley D. "Identification and quantification
of the indole alkaloid ibogaine in biological samples by gas chromatography-mass
spectrometry.", Biochemical Pharmacology, (January 6, 1995), 49(1), 73-79. PDF (597 KB)

Geigy, J. R. "Decarboxylation of alkyl esters of nitrogen-containing
unsaturated acids.", Swiss patent, (November 30, 1963), 372,291.

Geigy, J. R. "Decarboxylation of the indole group ester alkaloids.", German
patent, (July 5, 1962), 1,132,561.

Gershon, S. and Bell, C. "A study of the antagonism of some indole alkaloids
to the behavior effects of Ditran.", Medicina Experimentalis, (1963), 8, 15-27.

Gershon, S. and Lang, W. J. "A psycho-pharmacological study of some indole
alkaloids.", Archives Internationales de Pharmacodynamie, (1962), 135(1-2),
31-56. PDF (1.9 MB)

Ghorbel, N. and Damak, M. "Contribution a l'etude des Tabernaemontanees
americaines. IV. Alcaliodes de Peschiera echinata.", Journal of Natural
Products, (1981), 44, 717-721 (French). PDF (542
KB)

Glick, Stanley D.; Maisonneuve, Isabelle M. and Pearl, Sandra M. "Evidence
for roles of kappa-opioid and NMDA receptors in the mechanism of action of
ibogaine.", Brain Research, (1997), 749(2), 340-343. PDF (482 KB)

Glick, S. D.; Kuehne, M. E.; Maisonneuve, I. M.; Bandarage, U. K. and
Molinari, H. H. "18-Methoxycoronaridine, a non-toxic iboga alkaloid congener:
effects on morphine and cocaine self-administration and on mesolimbic dopamine
release in rats.", Brain Research, (1996), 719(1-2), 29-35. PDF (1.1 MB)

Glick, S. D.; Pearl, S. M.; Cai, J. and Maisonneuve, I. M. "Ibogaine-like
effects of noribogaine in rats.", Brain Research, (March 25, 1996), 713(1-2),
294-297. PDF (468 KB)

Glick, S. D.; Kuehne, M. E.; Raucci, J.; Wilson, T. E.; Larson, E.; Keller,
Jr. R. W. and Carlson, J. N. "Effects of iboga alkaloids on morphine and cocaine
self-administration in rats: relationship to tremorgenic effects and to effects
on dopamine release in nucleus accumbens and striatum.", Brain Research, (1994),
657, 14-22.

Glick, S. D.; Rossman, K.; Wang, S.; Dong, N. and Keller, R. W. Jr. "Local
effects of ibogaine on extracellular levels of dopamine and its metabolites in
nucleus accumbens and striatum: interactions with D-amphetamine.", Brain
Research, (November 19, 1993), 628(1-2), 201-208. PDF (874 KB)

Glick, S. D.; Rossman, K.; Rao, N. C.; Maisonneuve, I. M. and Carlson, J. N.
"Effects of ibogaine on acute signs of morphine withdrawal in rats: independence
from tremor.", Neuropharmacology, (1992), 31(5), 497-500.

Glick, Stanley D.; Gallagher, Carol A.; Hough, Lindsay B.; Rossman, Kent L.
and Maisonneuve, Isabelle M. "Differential effects of ibogaine pretreatment on
brain levels of morphine and (+)-amphetamine.", Brain Research, (1992), 588,
173-176. PDF (434 KB)

Glick, S. D.; Rossman, K.; Steindorf, S.; Maisonneuve, I. M. and Carlson, J.
N. "Effects and aftereffects of ibogaine on morphine self-administration in
rats.", European Journal of Pharmacology, (1991), 195, 341-345. PDF (546 KB)

Goldblatt, A.; Hootele, C. and Pecher, J. "The alkaloids of Voacanga
thouarsii var. Obtusa.", Phytochemistry, (1970), 9(6), 1293-1298. PDF (929 KB)

Gollnhofer, O. and Sillans, R. "Usages rituels de l'iboga au Gabon [Ritual
uses of iboga in Gabon].", Psychotropes, (1985), 2(3), 95-108 (French).

Gollnhofer, O. and Sillans, R. "L'iboga psychotrope Africain [Iboga, an
African psychotropic agent].", Psychotropes, (1983), 1(1), 11-27 (French).

Goutarel, M.; Janot, M.-M.; Mathys, F. and Prelog, V. "Uber das Ibolutein.",
Helvetica Chimica Acta, (1956), 39, 742-748 (German). PDF (678 KB)

Goutarel, R.; Gollnhofer, O. and Sillans, R. "Pharmacodynamics and
therapeutic applications of iboga and ibogaine.", Psychedelic Monographs and
Essays, (1993), 6, 71-111.

Goutarel, R.; Gollnhofer, O. and Sillans, R. "L'iboga contre la dependence
aux stupefiants pharmacodynamie et applications psychotherapeautiques.",
Psychotropes, (1993), 3(3), 63-86 (French).

Goutarel, R.; Poisson, J.; Croquelois, G.; Rolland, Y. and Miet, C.
"[Constituents of seeds of Tabernanthe iboga Baillon. I. Alkaloids].", Annales
Pharmaceutiques Francaises, (September-October 1974), 32(9-10), 521-524
(French). PDF (396 KB)

Goutarel, R.; Percheron, F.; Wohlfahrt, J. and Janot, M. M. "Structure of the
alkaloids of iboga.", Annales Pharmaceutiques Francaises, (1957), 15, 353-360.

Goutarel, Robert; Janot, Maurice Marie; Mathys, Frederic and Prelog, Vlado.
"Structure of ibogaine.", Comptes Rendus, (1953), 237, 1718-1720.

Gui, Liu; Xin, Liu and Xiao-zhang, Feng. "Ervayunine: A new indole alkaloid
from Ervatamia yunnanensis.", Planta Medica, (1988), 54(6), 519-521. PDF (293 KB)

Haller, A. and Heckel, Ed. "Sur l'ibogine, principe actif d'une plante du
genre Tabernaemontana, originaire du Congo.", Comptes Rendus Hebdomadaires des
Seances de l'Academie des Sciences, (1901), 133, 850-853 (French). PDF (545 KB)

Harmouche, A.; Mehri, H.; Koch, M.; Rabaron, A.; Plat, M. and Sevenet, T.
"Plants of New Caledonia. XXXIX. Alkaloids from leaves of Pagiantha cerifera
Mkgf. (Apocynaceae).", Annales Pharmaceutiques Francaises, (1976), 34(1-2),
31-35 (French).

Harsing, L. G. Jr.; Sershen, H. and Lajtha, A. J. "Evidence that ibogaine
releases dopamine from the cytoplasmic pool in isolated mouse striatum.",
Journal of Neural Transmission, (1994), 96, 215-225.

Hearn, W. L.; Pablo, J.; Hime, G. W. and Mash, D. C. "Identification and
quantification of ibogaine and O-demethylated metabolite in brain and biological
fluids using gas chromatography mass spectrometry.", Journal of Analytical
Toxicology, (October 1995), 19(6), 427-434.

Hedberg, Inga; Hedberg, Olov; Madati, Posanyi J.; Mshigeni, Keto E.; Mshiu,
E. N. and Samuelsson, Gunnar. "Inventory of plants used in traditional medicine
in Tanzania. I. Plants of the families Acanthaceae-Cucurbitaceae.", Journal of
Ethnopharmacology, (1982), 6(1), 29-60. PDF (2.6
MB)

Heggenhougen, H. Kris. "Reaching new highs: Alternative therapies for drug
addicts.", Jason Aronson, Inc, Northvale, NJ, USA, (1997), 208 pp.

Helsley, S.; Fiorella, D.; Rabin, R. A. and Winter, J. C. "Effects of
ibogaine on performance in the 8-arm radial maze.", Pharmacology, Biochemistry
and Behavior, (1997), 58(1), 37-41. PDF (480 KB)

Helsley, S.; Dlugos, C. A.; Pentney, R. J.; Rabin, R. A. and others. "Effects
of chronic ibogaine treatment on cerebellar Purkinje cells in the rat.", Brain
Research, (1997), 759(2), 306-308. PDF (349 KB)

Helsley, Scott; Rabin, Richard A. and Winter, J. C. "The effects of
noribogaine and harmaline in rats trained with ibogaine as a discriminative
stimulus.", Life Sciences, (1997), 60(9), PL147-PL153. PDF (645 KB)

Hider, C. L. "Rapid identification of frequently abused drugs.", Journal of
the Forensic Science Society, (1971), 11(4), 257-262.

Hofmann, Albert. "Structure and synthesis of hallucinogens.", Svensk
Farmaceutisk Tidskrift, (1971), 75(22), 933-940 (Swedish).

Hough, Lindsay B.; Pearl, Sandra M. and Glick, Stanley D. "Tissue
distribution of ibogaine after intraperitoneal and subcutaneous
administration.", Life Sciences, (1996), 58(7), PL119-122. PDF (348 KB)

House, Robert V.; Thomas, Peter T. and Bhargava, Hemendra N. "Comparison of
the hallucinogenic indole alkaloids ibogaine and harmaline for potential
immunomodulatory activity.", Pharmacology, (June 1995), 51(1), 56-65. PDF (1.1 MB)

Hwang, Bruce; Weisbach, Jerry A.; Douglas, Bryce; Raffauf, Robert F.; Cava,
Michael P. and Bessho, Kiyoshi. "The alkaloids of Peschiera lundii (D. C.)
Miers. Isolation and structure elucidation of voacristine pseudoindoxyl and
iboxygaine hydroxyindolenine.", Journal of Organic Chemistry, (1969), 34(2),
412-415. PDF (667 KB)

Ito, Kazuo. "Ibogenine and related basic substances.", Gifu Yakka Daigaku
Kiyo, (1961), 11, 9-28.

Jacobson, A. E. "Biological evaluation of compounds for their physical
dependence potential and abuse liability. XIII. Drug testing program of the
Committee on Problems of Drug Dependence, Inc.", NIDA Research Monograph,
(1990), 95, 563.

Jane, I.; McKinnon, A. and Flanagan, R. J. "High-performance liquid
chromatographic analysis of basic drugs on silica columns using non-aqueous
ionic eluents. II. Application of UV, fluorescence and electrochemical oxidation
detection.", Journal of Chromatography, (1985), 323(2), 191-225.

Janot, Maurice-Marie and Goutarel, Robert. "Derivatves of the ibogaine
alkaloids.", Unites States patent, (November 19, 1957), 2,813,873. PDF (316 KB)

Janot, Maurice-Marie and Goutarel, Robert. "Alcaloides des Voacanga:
Voacamine et vobtusine.", Comptes Rendus Hebdomadaires des Seances de l'Academie
des Sciences, (1955), 240, 1719-1720 (French). PDF
(246 KB)

Janot, Maurice-M.; Goutarel, R. and Sneeden, R. P. A. "Ibogaine.", Helvetica
Chimica Acta, (1951), 34, 1205-1207 (French).

Janot, Maurice-Marie and Chaigneau, Marcel. "[Sublimation of alkaloids under
reduced pressure.]", Comptes Rendus, (1947), 225, 1371-1373 (French). PDF (468 KB)

Japp, Margaret; Gill, Richard and Osselton, M. David. "Comparison of drug
retention indexes determined on packed, wide bore capillary and narrow bore
capillary columns.", Journal of Forensic Sciences, (1987), 32(6), 1574-1586.

Jenks, Christopher W. "Extraction Studies of Tabernanthe Iboga and Voacanga
Africana.", Natural Product Letters, (2002), 16(1), 71-76. PDF (402 KB)

Jetter, Alexis. "The psychedelic cure. (using ibogaine to treat drug
addiction).", New York Times, (Sunday, April 10, 1994), p50.

Jones, Stacy J. "Use of ibogaine to fight addiction. (patent no.
4,587,243).", New York Times, (Saturday, May 10, 1986), 135(19N), 37(L).

Judd, B. "Ibogaine, psychotherapy, and the treatment of substance-related
disorders.", Eighth International Conference on Drug Related Harm, (1994).

Jules, Oswald; Scypinski, Stephen and Love, L. J. Cline. "Fluorescence
enhancement of several hallucinogenic drugs in cyclodextrin media.", Analytica
Chimica Acta, (1985), 169, 355-360.

Kan, Christiane; Henriques, Amelia; Jasor, Yves; Moretti, Christian and
Husson, Henri-Philippe. "[Indole alkaloids from Stenosolen heterophyllus:
tabernamine and isotabernamine.]", Journal of Natural Products, (1984), 47(3),
478-481 (French). PDF (490 KB)

Kaplan, C. D; Ketzer, E; de Jong, J. and de Vries, M. "Reaching a state of
wellness: Multistage explorations in social neuroscience.", Social Neuroscience
Bulletin, (1993), 6(1), 6-7.

Keefner, S. M. and Glick, S. D. "Ibogaine antagonism of morphine-induced
hyperactivity: enhancement by prior morphine exposure and role of kappa opioid
receptors.", Society of Neuroscience Abstracts, (1994), 20, 502.5.

Kelley, J. M. and Adamson, R. H. "A comparison of common interatomic
distances in serotonin and some hallucinogenic drugs.", Pharmacology, (1973),
10, 28-31. PDF (510 KB)

Kesner, Raymond P.; Jackson-Smith, Pamela; Henry, Clarissa and Amann, Kelly.
"Effects of ibogaine on sensory-motor function, activity, and spatial learning
in rats.", Pharmacology Biochemistry and Behavior, (May 1995), 51(1), 103-109.
PDF (837 KB)

Khasawneh, I. M.; Garcia Alvarez-Coque, M. C.; Ramis Ramos, G. and
Winefordner, J. D. "Low- and room-temperature phosphorescence characteristics of
some pharmaceutical compounds.", Journal of Pharmaceutical and Biomedical
Analysis, (1989), 7(1), 29-38.

Knox, John R. and Slobbe, Jacob. "Indole alkaloids from Ervatamia orientalis.
I. Isolation of alkaloids and structural identification of two dimers.",
Australian Journal of Chemistry, (1975), 28(8), 1813-1823. PDF (2.0 MB)

Kostowski, W.; Rewerski, W. and Piechocki, T. "Effects of some hallucinogens
on aggressiveness of mice and rats. II.", Pharmacology, (1972), 7(4), 259-263.

Kusumoto, Ines Tomoco; Hattori, Masao; Miyaichi, Yukinori; Tomimori,
Tsuyoshi; Hanaoka, Miyoji and Namba Tsuneo. "Effects of flavonoids and alkaloids
on reverse transcriptase.", Shoyakugaku Zasshi, (1991), 45(3), 240-254.

Lambin, Suzanna and Bernard, Jacqueline. "Action of alkaloids on bacteria.",
Annales de l'Institut Pasteur, (1953), 85, 757-773.

Layer, Richard T.; Skolnick, Phil; Bertha, Craig M.; Bandarage, Upul K.;
Kuehne, Martin E. and Popik, Piotr. "Structurally modified ibogaine analogs
exhibit differing affinities for NMDA receptors.", European Journal of
Pharmacology, (1996), 309(2), 159-165. PDF (939 KB)

Le Men, Jean; Le Men-Oliver, Louisette; Levy, Jean; Levy-Appert-Colin, Marie
C. and Hannart, Jean. "N-Substituted indole compounds, dihydroindole
derivatives, and indole compounds.", German patent, (September 26, 1974),
2,410,651 (German).

Le Men, Jean; Le Men-Olivier, Mrs.; Levy, Jean; Appert-Collin-Levy, Marie C.
and Hannart, Jean. "N-Substituted indole compounds and dihydroindole and
N-substituted dihydroindole derivatives.", Belgian patent, (July 2, 1973),
796,521.

Le Men-Olivier, Louisette M. T.; Levy, Jean; Levy-Appert-Collin, Marie C.;
Hannart, Jean and Le Men, Jean. "Derivatives of iboga alkaloids.", German
patent, (May 15, 1975), 2,450,188 (German).

Leal, Mirna Bainy; Michelin, Ka´tia; Souza, Diogo Onofre Souza and
Elisabetsky, Elaine. "Ibogaine attenuation of morphine withdrawal in mice: role
of glutamate N-methyl-D-aspartate receptors.", Progress in
Neuro-Psychopharmacology & Biological Psychiatry, (2003), 27, 781-785. PDF (171 KB)

Lepri, L.; Desideri, P. G. and Lepori, M. "Chromatographic behavior of
alkaloids on thin layers of cation exchangers. II. Alginic acid, Rexyn 102,
Dowex 50-X4 and sodium carboxymethylcellulose.", Journal of Chromatography,
(1976), 123(1), 175-184.

Lerner, Melvin and Katsiaficas, Mary D. "Analytical separations of mixtures
of hallucinogenic drugs.", Bulletin on Narcotics, (1969), 21(1), 47-51.

Levy, M. C.; Debray, M.-M.; Le Men-Olivier, L. and Le Men, J. "[Alkaloids of
Pandaca speciosa.]", Phytochemistry, (1975), 14(2), 579-580 (French). PDF (241 KB)

Ley, F. Robert; Jeffcoat, A. Robert and Thomas, Brian F. "Determination of
ibogaine in plasma by gas chromatography-chemical ionization mass
spectrometry.", Journal of Chromatography A, (February 2, 1996), 723(1),
101-109. PDF (958 KB)

Lloyd, H. A.; Fales, H. M.; Highet, P. F.; VandenHeuuel, W. J. A. and
Wildman, W. C. "Separation of alkaloids by gas chromatography.", Journal of the
American Chemical Society, (1960), 82, 3791.

Long, R. and Lessin, A. W. "Inhibition of 5-hydroxytryptamine uptake by
platelets in vitro and in vivo.", The Biochemical Journal, (1962), 82, 4P-5P.

Lotsof, Howard S. "Ibogaine in the treatment of chemical dependence
disorders: clinical perspectives.", Bulletin of the Multidisciplinary
Association for Psychedelic Studies, (1995), 5(3), 16-27.

Lotsof, Howard S. "Rapid method for interrupting or attenuating poly-drug
dependency syndromes.", Unites States patent, (1992), 5,152,994. PDF (423 KB)

Lotsof, Howard S. "Rapid method for interrupting or attenuating the
nicotine/tobacco dependency syndrome.", Unites States patent, (1991), 5,026,697.
PDF (359 KB)

Lotsof, Howard S. "Rapid method for attenuating the alcohol dependency
syndrome.", United States patent, (1989), 4,857,523. PDF (455 KB)

Lotsof, Howard S. "Rapid method for interrupting the cocaine and amphetamine
abuse syndrome.", United States patent, (1986), 4,587,243. PDF (421 KB)

Lotsof, Howard S. "Rapid method for interrupting the narcotic addiction
syndrome.", United States patent, (1985), 4,499,096. PDF (426 KB)

Love, L. J. Cline; Grayeski, Mary Lynn; Noroski, Joyce and Weinberger,
Robert. "Room-temperature phosphorescence, sensitized phosphorescence and
fluorescence of licit and illicit drugs enhanced by organized media.", Analytica
Chimica Acta, (1985), 170(1), 3-12.

Luxton, T.; Parker, L. A. and Siegel, S. "Ibogaine fails to interrupt the
expression of a previously established one-trial morphine place preference.",
Progress in Neuro-Psychopharmacology and Biological Psychiatry, (1996), 20(5),
857-872.

Mach, R. H.; Smith, C. R. and Childers, S. R. "Ibogaine possesses a selective
affinity for sigma(2) receptors.", Life Sciences, (June 16, 1995), 57(4),
PL57-62.

Maisonneuve, I. M.; Mann, G. L.; Deibel, C. R. and Glick, S. D. "Ibogaine and
the dopaminergic response to nicotine.", Psychopharmacology, (1997), 129(3),
249-256. PDF (952 KB)

Maisonneuve, I. M. and Glick, S. D. "Interactions between ibogaine and
cocaine in rats: in vivo microdialysis and motor behavior.", European Journal of
Pharmacology, (1992), 212, 263-266. PDF (410
KB)

Maisonneuve, I. M.; Keller, R. W. Jr. and Glick, S. D. "Interactions of
ibogaine and D-amphetamine: in vivo microdialysis and motor behavior in rats.",
Brain Research, (1992), 579, 87-92. PDF (690
KB)

Maisonneuve, I. M.; Rossman, K. L.; Keller, R. W. Jr. and Glick, S. D. "Acute
and prolonged effects of ibogaine on brain dopamine metabolism and
morphine-induced locomotor activity in rats.", Brain Research, (1992), 575,
69-73. PDF (538 KB)

Maisonneuve, Isabelle Marie. "Ibogaine and brain dopamine systems:
interactions with drugs of abuse (morphine, amphetamine, cocaine).",
Dissertation Abstracts International. B, Science and Engineering. (1992),
52(11), 5773.

Maisonneuve, I. M.; Keller, R. W. Jr. and Glick, S. D. "Interactions between
ibogaine, a potential anti-addictive agent, and morphine: an in vivo
microdialysis study.", European Journal of Pharmacology, (1991), 199, 35-42. PDF (889 KB)

Mandrile, Eloy L. and Bongiorno de Pfirter, Graciela M. "Natural active
principles with hallucinogenic effects. VI. Ibogaine. Its presence in
Tabernanthe iboga Baill. H. Bn. (Apocynaceae).", Acta Farmaceutisk Bonaerense,
(1985), 4(1), 49-64 (Spanish).

Mash, Deborah C.; Staley, Julie K.; Baumann, Michael H.; Rothman, Richard B.
and Hearn, W. L. "Identification of a primary metabolite of ibogaine that
targets serotonin transporters and elevates serotonin.", Life Sciences, (June 9,
1995), 57(3), PL45-PL50.

Mash, D. C.; Staley, J. K.; Pablo, J. P.; Holohean, A. M.; Hackman, J. C. and
Davidoff, R. A. "Properties of ibogaine and its principal metabolite
(12-hydroxyibogamine) at the MK-801 binding site of the NMDA receptor complex.",
Neuroscience Letters, (1995), 192(1), 53-56.

Mash, D. C.; Douyon, R.; Hearn, W. L.; Sambol, N. C. and Sanchez-Ramos, J. "A
preliminary report on the safety and pharmacokinetics of ibogaine.", Biological
Psychiatry, (1995), 37, 652.

Matwyshyn, G. A. and Bhargava, H. N. "Effect of ibogaine on morphine and U
50,488H induced analgesia and hypothermia in the mouse.", FASEB Journal, (1996),
10, 2618.

Milani, B. "[On the pharmacologic action of Tabernanthe Iboga. Collective
review and clinical contribution].", Rassegna di Studi Psichiatrici, (1965),
54(2), 185-198 (Italian).

Miller, Greg. "FDA advisers OK human testing of hallucinogen (Food and Drug
Administration Drug Abuse Advisory Committee allows testing of ibogaine).", Los
Angeles Times, (Thursday, August 26, 1993), 112, A15, col 1.

Molinari, H. H.; Maisonneuve, I. M. and Glick, S. D. "Ibogaine neurotoxicity:
a re-evaluation.", Brain Research, (1996), 737(1-2), 255-262. PDF (963 KB)

Molinari, H. H.; Maisonneuve, I. M. and Glick, S. D. "Dose dependence of
ibogaine neurotoxicity.", Society for Neuroscience Abstracts, (1994), 20, 504.4.

Moroz, Isabella; Parker, Linda A. and Siegel, Shepard. "Ibogaine interferes
with the establishment of amphetamine place preference learning.", Experimental
& Clinical Psychopharmacology, (1997), 5(2), 119-122.

Mulamba, T.; Delaude, C.; Le Men-Oliver, L. and Levy, J. "Alcaloides de
Tabernanthe pubescens.", Journal of Natural Products, (1981), 44(2), 184-189
(French). PDF (881 KB)

Musumarra, Giuseppe; Scarlata, Giuseppe; Romano, Guido; Clementi, Sergio and
Wold, Svante. "Application of principal components analysis to TLC data for 596
basic and neutral drugs in four eluent systems.", Journal of Chromatographic
Science, (1984), 22(12), 538-547.

Nadis, Steve. "The mystery of ibogaine: can an African psychedelic cure
addiction?", Omni, (July 1993), 15(9), 14. PDF (133
KB)

Naranjo, C. "The Healing Journey.", Pantheon Books, Div. Random House, NY,
(1973), 174-228.

Naranjo, C. "Psychotherapeutic possibilities: New fantasy enhancing drugs.",
Clinical Toxicology, (1969), 2(2), 209-224.

Nelson, D. L.; Herbert, A.; Petillot, Y.; Pichat, L.; Glowinski, J. and
Hamon, M. "[3H]Harmaline as a specific ligand of MAO A. I. Properties of the
active site of MAO A from rat and bovine brains.", Journal of Neurochemistry,
(1979), 32(6), 1817-1827.

Neuss, Norbert. "Alkaloids from Apocyanaceae. II. Ibogaline, a new alkaloid
from Tabernanthe iboga Baill.", Journal of Organic Chemistry, (1959), 24,
2047-2048. PDF (380 KB)

Nielsen, Helene B.; Hazell, Alan; Hazell, Rita; Ghia, Felipe and Torssell,
Kurt B. G. "Indole alkaloids and terpenoids from Tabernaemontana markgrafiana.",
Phytochemistry, (1994), 37(6), 1729-1735. PDF (970
KB)

O'Callaghan, James P.; Rogers, Tina S.; Rodman, Larry E. and Page, John G.
"Acute and chronic administration of ibogaine to the rat results in astrogliosis
that is not confined to the cerebellar vermis.", Annals of the New York Academy
of Sciences, (1996), 801, 205-216. PDF (650 KB)

O'Hearn, E.; Zhang, P. and Molliver, M. E. "Excitotoxic insult due to
ibogaine leads to delayed induction of neuronal NOS in purkinje cells.",
Neuroreport, (August 21, 1995), 6(12), 1611-1616.

O'Hearn, E.; Long, D. B. and Molliver, M. E. "Ibogaine induces glial
activation in parasagittal zones of the cerebellum.", Neuropharmacology and
Neurotoxicology, (1993), NeuroReport 4, 299-302.

O'Hearn, E. and Molliver, M. E. "Degeneration of purkinje cells in
parasagittal zones of the cerebellar vermis after treatment with ibogaine or
harmaline.", Neuroscience, (1993), 55(2), 303-310. PDF (1.2 MB)

Omnium Chimique, S. A. "Oxidation derivatives of alkaloids.", Belgian patent,
(February 15, 1974), 806,438.

Onwere, I.; Chakrabarti, A.; Ali, S. F. and Onaivi, E. S. "Effect of ibogaine
on cocaine withdrawal anxiogenesis in mice.", FASEB Journal, (1996), 10, 2595.

Ott, Jonathan. "Pharmacotheon: entheogenic drugs, their plant sources and
history.", Kennewick, WA: Natural Products Co., (1993), 371-373. PDF (629 KB)

Palumbo, Patricia A. and Winter, J. C. "Stimulus effects of ibogaine in rats
trained with yohimbine, DOM, or LSD.", Pharmacology Biochemistry and Behavior,
(December 1992), 43(4), 1221-1226. PDF (776 KB)

Panas, J. M.; Richard, B.; Sigaut, C.; Debray, M.-M.; Le Men-Olivier, L. and
Le Men, J. "[Alkaloids of Pandaca ochrascens.]", Phytochemistry, (1974), 13(9),
1969-1974 (French). PDF (769 KB)

Paris, Rene and Vairel, Claude. "The effect of iboga and ibogaine on the
muscle chronaxia.", Comptes Rendus, (1949), 228, 436-438.

Parker, Linda A. and Siegel, Shepard. "Ibogaine interferes with the
establishment of conditioned taste avoidance produced by morphine and lithium.",
Learning and Motivation, (1996), 27(2), 170-178.

Parker, Linda A.; Siegel, Shepard and Luxton, Tracey. "Ibogaine attenuates
morphine-induced conditioned place preference.", Experimental & Clinical
Psychopharmacology, (November 1995), 3(4), 344-348.

Patel, Mahendra B.; Miet, Christine and Poisson, Jacques. "Alkaloids from
some African Tabernaemontana.", Annales Pharmaceutiques Francaises, (1967),
25(5), 379-384 (French).

Pearl, S. M.; Hough, L. B.; Boyd, D. L. and Glick, S. D. "Sex differences in
ibogaine antagonism of morphine-induced locomotor activity and in ibogaine brain
levels and metabolism.", Pharmacology, Biochemistry and Behavior, (1997), 57(4),
809-815. PDF (882 KB)

Pearl, S. M.; Maisonneuve, I. M. and Glick, S. D. "Prior morphine exposure
enhances ibogaine antagonism of morphine-induced dopamine release in rats.",
Neuropharmacology, (1996), 35(12), 1779-1784.

Pearl, S. M.; Johnson, D. W. and Glick, S. D. "Prior morphine exposure
enhances ibogaine antagonism of morphine induced locomotor stimulation.",
Psychopharmacology, (October 1995), 121(4), 470-475.

Pearl, Sandra. M.; Herrick-Davis, Katherine.; Teitler, Milton. and Glick,
Stanley. D. "Radioligand-binding study of noribogaine, a likely metabolite of
ibogaine.", Brain Research, (March 27, 1995), 675(1-2), 342-344. PDF (223 KB)

Pecher, R. H. Martin; Defay, N.; Kaisin, M; Peeters, J. and Van Binst, G.
"Indole alkaloids. Presence of N(alpha)-CH group in voachalotine.", Tetrahedron
Letters, (1961), 270-273.

Percheron, Francois. "Some alkaloids of Iboga and of Voacanga (Apocynaces).",
Annales de Chimie, (1959), 4, 303-364 (French).

Percheron, Francois; Goutarel, Robert and Conreur, Christiane.
"Characterization of methyl and ethyl side chains by the method of Kuhn-Roth.",
Bulletin de la Societe Chimique de France, (1957), 1198-1200.

Percheron, Francois; Le Hir, Alain; Goutarel, Robert and Janot, Maurice
Marie. "'Ibogaine' and 'voacangine'.", Comptes Rendus, (1957), 245, 1141-1143.

Pope, H. G. Jr. "Tabernanthe iboga: An African narcotic plant of social
importance", Economic Botany, (1969), 23, 174-184.

Popik, Piotr and Glick, Stanley D. "Ibogaine: a putatively anti-addictive
alkaloid.", Drugs of the Future, (1996), 21(11), 1109-1115.

Popik, P. "Facilitation of memory retrieval by the 'anti-addictive' alkaloid,
ibogaine.", Life Sciences, (1996), 59(24), PL379-PL385.

Popik, Piotr; Layer, Richard T.; Fossom, Linda H.; Benveniste, Morris;
Geter-Douglass, B.; Witkin, J. M. and Skolnick, P. "NMDA antagonist properties
of the putative antiaddictive drug ibogaine.", Journal of Pharmacology and
Experimental Therapeutics, (November 1995), 275(2), 753-760.

Popik, Piotr; Layer, Richard T. and Skolnick, Phil. "100 Years of ibogaine -
neurochemical and pharmacological actions of a putative anti-addictive drug.",
Pharmacological Reviews, (1995), 47(2), 235-253.

Popik, P.; Layer, R. T. and Skolnick, P. "The Putative anti-addictive drug
ibogaine is a competitive inhibitor of [3H]MK-801 binding to the NMDA receptor
complex.", Psychopharmacology, (1994), 114, 672-674.

Quirin, F.; Debray, M.-M.; Sigaut, C.; Thepenier, P.; Le Men-Olivier, L. and
Le Men, J. "[Alkaloids of Pandaca eusepala.]", Phytochemistry, (1975), 14(3),
812-813 (French). PDF (246 KB)

Rabin, R. A. and Winter, J. C. "Ibogaine and noribogaine potentiate the
inhibition of adenylyl cyclase activity by opioid and 5-HT receptors.", European
Journal of Pharmacology, (1996), 316(2-3), 343-348.

Rabin, R. A. and Winter, J. C. "Effects of ibogaine and noribogaine on
phosphoinositide hydrolysis.", Brain Research, (1996), 731(1-2), 226-229.

Rahman, Atta-ur; Fatima, Talat; Nisa, Mehrun; Ijaz, S.; Crank, George and
Wasti, Shaheen. "Indole alkaloids from Trachelospermum jasminoides.", Planta
Medica, (1987), 53, 57-59.

Rapoport, Henry. The Alkaloids of Tabernanthe iboga., (1953).

Raymond-Hamet; Vincent, D. and Parant, M. "Action of some sympathicosthenic
alkaloids on cholinesterases.", Comptes Rendus des Seances de la Societe de
Biologie, (1956), 150, 1384-1386.

Raymond-Hamet. "Interpretation of the ultraviolet absorption curves of
ibogaine and tabernanthine.", Comptes Rendus, (1949), 229, 1359-1361.

Raymond-Hamet. "Sympathicosthenic action of ibogaine on the vessels of the
dog's paw.", Comptes Rendus, (1946), 223, 757-759.

Raymond-Hamet. "Some color reactions of ibogaine.", Bulletin de la Societe de
Chimie Biologique, (1943), 25, 205-210.

Raymond-Hamet. "Ibogaine.", Bulletin de la Societe Chimique de France,
(1942), 9, 620-622.

Raymond-Hamet. "Pharmacologic antagonism.", Comptes Rendus, (1941), 212,
768-771.

Raymond-Hamet. "Mediate and immediate effects of ibogaine on the intestine.",
Comptes Rendus des Seances de la Societe de Biologie, (1941), 135, 176-179.

Raymond-Hamet. "Ibogaine and ephedrine.", Comptes Rendus des Seances de la
Societe de Biologie, (1940), 134, 541-544.

Raymond-Hamet. "Difference between the physiological action of ibogaine and
that of cocaine.", Comptes Rendus, (1940), 211, 285-288. PDF (276 KB)

Raymond-Hamet. "Two physiological properties common to ibogaine and
cocaine.", Comptes Rendus des Seances de la Societe de Biologie, (1940), 133,
426-429. PDF (217 KB)

Raymond-Hamet and Rothlin, E. "Pharmacological action of ibogaine.", Archives
Internationales de Pharmacodynamie, (1939), 63, 27-39.

Reid, M. S.; Hsu, K.; Souza, K. H.; Broderick, P. A. and Berger, S. P.
"Neuropharmacological characterization of local ibogaine effects on dopamine
release.", Journal of Neural Transmission, (1996), 103(8-9), 967-985.

Reio, L. "Third supplement for the paper chromatographic separation and
identification of phenol derivatives and related compounds of biochemical
interest using a 'reference system'.", Journal of Chromatography, (1970), 47(1),
60-85.

Renner, U. and Prins, D. A. "[Voacanga alkaloids. III. Voacristine: its
identity to voacangarine and degradation to iboxygaine and ibogaine.]",
Experientia, (1959), 15(12), 456-457 (German). PDF
(334 KB)

Renner, U.; Prins, D. A. and Stoll, W. G. "[Alkaloids from Conopharyngia
durissima Stapf. Isovoacangine, conopharyngine, conodurine, and conoduramine.]",
Helvetica Chimica Acta, (1959), 42(5), 1572-1581 (German). PDF (1.4 MB)

Repke, David B.; Artis, Dean R.; Nelson, Janis T. and Wong, Erik H. F.
"Abbreviated ibogaine congeners. Synthesis and reactions of tropan-3-yl-2- and
-3-indoles. Investigation of an unusual isomerization of 2-substituted indoles
using computational and spectroscopic techniques.", Journal of Organic
Chemistry, (April 22, 1994), 59(8), 2164-2171. PDF
(1.2 MB)

Rezvani, A. H.; Overstreet, D. H. and Leef, Y. W. "Attenuation of alcohol
intake by ibogaine in three strains of alcohol-preferring rats.", Pharmacology
Biochemistry and Behavior, (November 1995), 52(3), 615-620.

Richard, B.; Delaude, C.; Massiot, G. and Le Men-Oliver, L. "Alkaloids from
Voacanga schweinfurthii var. Puberula.", Journal of Natural Products, (1983),
46(2), 283-284. PDF (292 KB)

Rolland, Yves; Croquelois, Guy; Kunesch, Nicole; Boiteau, Pierre; Debray,
Maurice; Pecher, Jacques and Poisson, Jacques. "[Alkaloids of the leaves of
Voacanga thouarsii.]", Phytochemistry, (1973), 12(8), 2039-2042 (French). PDF (706 KB)

Rosenmund, Peter; Haase, Wolfgang H.; Bauer, Juergen and Frische, Rainer.
"[Contributions to the chemistry of indole, VII. Syntheses in the Iboga-Series,
III. Ibogamine, ibogaine, and epiibogamine.]", Chemische Berichte, (1975),
108(6), 1871-1895 (German). PDF (3.1 MB)

Rothlin, E. and Raymond-Hamet. "Effect of ibogaine on the isolated rabbit
uterus.", Comptes Rendus des Seances de la Societe de Biologie, (1938), 127,
592-594.

Rothlin, E. and Raymond-Hamet. "Action of ibogaine (ibogine) on the isolated
seminal vesicle of the rabbit.", Comptes Rendus des Seances de la Societe de
Biologie, (1934), 116, 1340-1342.

Sallay, Stephen I. "The total synthesis of dl-ibogamine.", Journal of the
American Chemical Society, (December 6, 1967), 89(25), 6762-6763. PDF (280 KB)

Sallay, Stephen I. "An approach to the synthesis of ibogaine.", Tetrahedron
Letters, (1964), 36, 2443-2450. PDF (433 KB)

Salmoiraghi, Gian Carlo and Page, Irvine H. "Effects of lysergic acid
diethylamide (LSD 25), 2-bromolysergic acid diethylamide (BOL 148), bufotenine,
mescaline, and ibogaine on the potentiation of hexobarbital hypnosis produced by
serotonin and reserpine.", Journal of Pharmacology and Experimental
Therapeutics, (1957), 120, 20-25.

Sanchez-Ramos, J. and Mash, D. C. "Ibogaine research update: Phase I human
study.", Bulletin of the Multidisciplinary Association for Psychedelic Studies,
(1994), 4(4), 11.

Scallet, A. C.; Ye, X.; Rountree, R.; Nony, P. and Ali, S. F. "Ibogaine
produces neurodegeneration in rat, but not mouse, cerebellum. Neurohistological
biomarkers of Purkinje cell loss.", Annals of the New York Academy of Sciences,
(1996), 801, 217-226.

Scallet, A. C.; Ye, X. and Ali, S. F. "NOS and fos in rat and mouse brain
regions. Possible relation to ibogaine-induced Purkinje cell loss.", Annals of
the New York Academy of Sciences, (1996), 801, 227-238.

Scallet, A. C.; Ye, X.; Rountree, R. L.; Schmued, L. C. and Ati, S. F.
"Ibogaine, a putative treatment for drug-addiction -neuropathology in rats and
mice.", Brain Pathology, (1996), 6, 356.

Schechter, Martin D. "Serotonergic mediation of fenfluramine discriminative
stimuli in fawn-hooded rats.", Life Sciences, (1997), 60(6), PL83-PL90. PDF (827 KB)

Schechter, Martin D. and Gordon, Timothy L. "Comparison of the behavioral
effects of ibogaine from three sources: mediation of discriminative activity.",
European Journal of Pharmacology, (November 2, 1993), 249(1), 79-84. PDF (767 KB)

Schechter, Martin D. "Cocaine discrimination is attenuated by isradipine and
CGS 10746B.", Pharmacology Biochemistry and Behavior, (March 1993), 44(3),
661-664. PDF (546 KB)

Schleiffer, H. (Ed.) "Narcotic plants of the old world: An anthology of texts
from ancient times to the present.", Lubrecht & Cramer, Monticello,
NY,.(1979).

Schlittler, E.; Burckhardt, C. A. and Gellert, E. "[Fusion of ibogaine with
potassium hydroxide.]", Helvetica Chimica Acta, (1953), 36(6), 1337-1344
(German). PDF (831 KB)

Schmid, P. B. "[The psychic effect of ibogaline hydrochloride (alkaloid from
Tabernanthe iboga Baill)].", Arzneimittel-Forschung, (April 1967), 17(4),
485-490 (German). PDF (882 KB)

Schmued, L. C.; Albertson, C. and Slikker, W. Jr. "Fluoro-Jade: a novel
fluorochrome for the sensitive and reliable histochemical localization of
neuronal degeneration.", Brain Research, (1997), 751(1), 37-46. PDF (1.1 MB)

Schneider, A. S.; Nagel, J. E. and Mah, S. J. "Ibogaine selectively inhibits
nicotinic receptor-mediated catecholamine release.", European Journal of
Pharmacology, (1996), 317(2-3), R1-R2.

Schneider, Jurg Adolf. "Tabernanthine, ibogaine containing analgesic
compositions.", United States patent, (December 24, 1957), 2,817,623. PDF (388 KB)

Schneider, Jurg A. and Rinehart, Roy A. "Analysis of the cardiovascular
action of ibogaine hydrochloride.", Archives Internationales de Pharmacodynamie,
(1957), 110, 92-102.

Schneider, J. A. and Sigg, E. B. "Neuropharmacological studies on ibogaine,
an indole alkaloid with central-stimulant properties.", Annals New York Academy
of Sciences, (1957), 66, 765-776.

Schneider, J. A. and McArthur, Marie. "Potentiating action of ibogaine
(Bogadin TM) on morphine analgesia.", Experientia, (1956), 12(8), 323-324.

Schultes, Richard Evans and Hofmann, Albert. "The Botany and Chemistry of
Hallucinogens, 2nd ed.", C. C. Thomas, Springfield, IL, (1980), 233-240.

Scott, A. I. and Wei, C. C. "Regio- and stereospecific models for the
biosynthesis of the indole alkaloids. The Aspidosperma-Iboga relationship.",
Journal of the American Chemical Society, (1972), 94(23), 8266-8267.

Scott, A. I. and Qureshi, A. A. "Biogenesis of Strychnos, Aspidosperma, and
Iboga alkaloids. The structure and reactions of preakuammicine.", Journal of the
American Chemical Society, (1969), 91(21), 5874-5876. PDF (330 KB)

Seltzmann, H. H.; Odear, D. F.; Laudeman, C. P.; Carroll, F. I. and others.
"Metallation/reduction as a new approach to tritium labelling - the synthesis of
[H-3]ibogaine.", Journal of Labelled Compounds & Radiopharmaceuticals,
(April 1994), 34(4), 367-375.

Seltzman, Herbert H.; Odear, Denise F.; Carroll, F. Ivy and Wyrick,
Christopher D. "A new approach to tritium labelling; the synthesis of
[3H]ibogaine.", Journal of the Chemical Society-Chemical Communications,
(December 15, 1992), 24, 1757-1758.

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "Ibogaine and cocaine abuse:
Pharmacological interactions at dopamine and serotonin receptors.", Brain
Research Bulletin, (1997), 42(3), 161-168. PDF
(1.1 MB)

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "The effect of ibogaine on
sigma- and NMDA-receptor-mediated release of [3H]dopamine.", Brain Research
Bulletin, (1996), 40(1), 63-67.

Sershen, H.; Hashim, A. and Lajtha, A. "The effect of ibogaine on sigma- and
NMDA-receptor mediated release of (3H) dopamine.", Journal of Neurochemistry,
(1996), 66, S59. PDF (278 KB)

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "Effect of ibogaine on
cocaine-induced efflux of [3H]dopamine and [3H]serotonin from mouse striatum.",
Pharmacology Biochemistry and Behavior, (April 1996), 53(4), 863-869. PDF (830 KB)

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "The effect of ibogaine on
kappa-opioid- and 5-HT3-induced changes in stimulation-evoked dopamine release
in vitro from striatum of C57BL/6By mice.", Brain Research Bulletin, (1995),
36(6), 587-591. PDF (567 KB)

Sershen, Henry; Hashim, Audrey and Lajtha, Abel. "Effect of ibogaine on
serotonergic and dopaminergic interactions in striatum from mice and rats.",
Neurochemical Research, (1994), 19(11), 1463-1466. PDF (538 KB)

Sershen, H.; Hashim, A. and Lajtha, A. "Ibogaine reduces preference for
cocaine consumption in C57BL/6By mice.", Pharmacology Biochemistry and Behavior,
(January 1994), 47(1), 13-19.

Sershen, H.; Hashim, A. and Lajtha, A. "Ibogaine reduces preference for
cocaine consumption in C57BL/6By mice.", Pharmacology Biochemistry and Behavior,
(1993), 46, 942-948.

Sershen, H.; Harsing, L. G. Jr.; Hashim, A. and Lajtha, A. "Ibogaine reduces
amphe locomotor in C57L/6By mice, but stimulates locomotor activity in rats.",
Life Sciences, (1992), 51, 1003-1011.

Sershen, H.; Hashim, A.; Harsing, L. G. Jr. and Lajtha, A. "Ibogaine
antagonizes cocaine induced locomotor stimulation in mice.", Life Sciences,
(1992), 50, 1079-1086.

Shamma, M. and Soyster, H. E. "Rates of methiodide formation and the
stereochemistry of the ethyl side chain of Iboga type alkaloids.", Experientia,
(January 15, 1964), 20(1), 36-38.

Sharpe, L. G. and Jaffe, J. H. "Ibogaine fails to reduce
naloxone-precipitated withdrawal in the morphine dependent rat.", NIDA Research
Monograph, (1991), 105, 477.

Sharpe, L. G. and Jaffe, J. H. "Ibogaine fails to reduce
naloxone-precipitated withdrawal in the morphine-dependent rat.",
Neuropharmacology and Neurotoxicology, (1990), 1, 17-19.

Shen, Tsung-Ying. "Medicinal chemical studies of anti-inflammatory and
analgesic natural products.", Journal of the Chinese Chemical Society, (1995),
42, 617-621. PDF (552 KB)

Sheppard, Simon G. "A preliminary investigation of ibogaine: case reports and
recommendations for further study.", Journal of Substance Abuse Treatment,
(1994), 11(4), 379-385. PDF (811 KB)

Siek, T. J. "Identification of drugs and other toxic compounds from their
ultraviolet spectra. I. Ultraviolet absorption properties of sixteen structural
groups.", Journal of Forensic Sciences, (1974), 19(2), 193-214.

Singbartl, G.; Zetler, G. and Schlosser, Lucie. "Structure-activity
relationships of intracerebrally injected tremorigenic indole alkaloids.",
Neorupharmacology, (1973), 12(3), 239-244. PDF
(734 KB)

Singbartl, G.; Zetler, G. and Schlosser, Lucie. "Pharmacokinetic studies on
structure-activity relationship of tremor-producing harmala and iboga
alkaloids.", Naunyn-Schmiedeberg's Archives of Pharmacology, (1972), 274, R109.
PDF (126 KB)

Sisko, B. "Interrupting drug dependency with ibogaine: a summary of four case
histories.", Bulletin of the Multidisciplinary Association for Psychedelic
Studies, (1993), 4(2), 15-24.

Sloviter, Robert S.; Drust, Eugene G.; Damiano, Bruce P. and Connor, John D.
"A common mechanism for lysergic acid, indolealkylamine and phenethylamine
hallucinogens: serotonergic mediation of behavioral effects in rats.", The
Journal of Pharmacology and Experimental Therapeutics, (1980), 214(2), 231-238.
PDF (1.2 MB)

Smith, C. M. and Abood, L. G. "The action of some CNS [central nervous
system] and local anesthetic drugs on the stimulated glycolysis of frog
sartorius muscle.", International Journal of Neuropharmacology, (1966), 5(3),
255-261.

Soriano-Garcia, M. "Structure of ibogaine.", Acta Crystallographica Section
C-Crystal Structure Communications, (November 15, 1992), 48, 2055-2057. PDF (538 KB)

Stafford, Peter. "Psychedelics Encyclopedia", Ronin Publishing Inc.,
Berkeley, CA, (1992), 358-367.

Staley, Julie K.; Ouyang, Qinjie; Pablo, John; Hearn, W. Lee; Flynn, Donna
D.; Rothman, Richard B.; Rice, Kenner C. and Mash, Deborah C. "Pharmacological
screen for activities of 12-hydroxyibogamine: a primary metabolite of the indole
alkaloid ibogaine.", Psychopharmacology, (1996), 127(1), 10-18. PDF (1.2 MB)

Stauffacher, D. and Seebeck, E. "[Voacangerine, a new alkaloid from Voacanga
africana Stapf.]", Helvetica Chimica Acta, (1958), 41(1), 169-180. PDF (1.6 MB)

Sweetnam, P. M.; Lancaster, J.; Snowman, Adele; Collins, J. L. and others.
"Receptor binding profile suggests multiple mechanisms of action are responsible
for ibogaine's putative anti-addictive activity.", Psychopharmacology, (April
1995), 118(4), 369-376.

Talapatra, S. K.; Sen Gupta, S.; Bhattacharya, M. and Talapatra, B.
"Alkaloids of Tabernaemontana wallichiana.", Indian Journal of Chemistry,
Section B: Organic Chemistry, Including Medicinal Chemistry, (1976), 14B(5),
385-387. PDF (465 KB)

Tatevosyan, G. T. "Alkaloids of the ibogaine group.", U Spekhi Khim., (1959),
28, 990-1010.

Taub, Eric. "Free at last - ibogaine, the African connection", Magical Blend,
(April 1995), 46, 31-36.

Taylor, W. I. "The Iboga and Voacanga alkaloids.", The Alkaloids, Chemistry
and Physiology, Akademic Press, New York , (1968), 11, 79-98.

Taylor, W. I. "The Iboga and Voacanga alkaloids.", The Alkaloids, Chemistry
and Physiology, R. H. F. Manske, Ed: Academic Press, New York, (1965), Volume 8,
203-235. PDF (3.4 MB)

Taylor, William Irving. "Process for the manufacture of indoles and products
obtained thereby.", United States patent, (March 10, 1959), 2,877,229. PDF (536 KB)

Taylor, W. I. "The biogenesis of the Tabernanthe iboga alkaloids.",
Experientia, (1957), 13, 454.

Taylor, W. I. "Iboga alkaloids. II. Structures of ibogaine, ibogamine, and
tabernanthine.", Journal of the American Chemical Society, (1957), 79,
3298-3299.

Thomas, David. W. and Biemann, K. "The alkaloids of Voacanga africana.",
Lloydia, (1968), 31(1), 1-8.

Touchette, Nancy. "Anti-addiction drug ibogaine on trial.", Nature Medicine,
(April 1995), 1(4), 288-289.

Tuomisto, J.; Walaszek, E. J. and Pazdernik, T. L. "Inhibition of histamine
uptake in platelets by alkaloids.", Annales Medicinae Experimentalis et
Biologiae Fenniae, (1973), 51(2), 59-64.

Turner, Wm. J.; Merles, Sidney and Carl, Ann. "Concerning theories of indoles
in schizophrenigenesis.", American Journal of Psychiatry, (1955), 112, 466-467.
PDF (291 KB)

Valette, G. and Leclair, M. F. "[The effect of alkaloids from Tabernanthe
iboga H. Bn. on the response of isolated organs to catecholamines and the
possible role of calcium exchange. Case of Ibogaine].", Comptes Rendus
Hebdomadaires des Seances de L Academie des Sciences. D: Sciences Naturelles,
(October 31, 1977), 285(11), 1147-1150 (French).

Valette, G. and Leclair, M. F. "[Effects of Tabernanthe iboga H. Bn.
alkaloids on the isolated organ responses to catecholamines and the role of
calcium exchanges. Tabernanthine].", Comptes Rendus Hebdomadaires des Seances de
L Academie des Sciences. D: Sciences Naturelles, (September 19, 1977), 285(5),
591-594 (French).

van Beek, T. A.; de Smidt, C. and Verpoorte, R. "Phytochemical investigation
of Tabernaemontana crassa.", Journal of Ethnopharmacology, (1985), 14(2-3),
315-318. PDF (260 KB)

van Beek, T. A.; Verpoorte, R.; Svendsen, A. Baerheim; Leeuwenberg, A. J. M.
and Bisset, N. G. "Tabernaemontana L. (Apocynaceae): A review of its taxonomy,
phytochemistry, ethnobotany and pharmacology.", Journal of Ethnopharmacology,
(1984), 10(1), 1-156. PDF (8.4 MB)

van Beek, T. A.; Verpoorte, R. and Baerheim Svendsen, A. "Identification of
Tabernaemontana alkaloids by means of thin-layer chromatography and chromogenic
reactions.", Journal of Chromatography, (1984), 298(2), 289-307.

van Beek, T. A. "Pharmacognostical studies of some Tabernaemontana species.",
Ph. D. Dissertation, Rijksuniversiteit Leiden, (1984), 161p.

van Binst, G.; Dewaersegger, L. and Martin, Richard Henri. "Application of
gas-phase chromatography to the study of products of pyrolysis of indole
alkaloids. II. Interpretation of the pyrograms, and discussion.", Journal of
Chromatography, (1966), 25(1), 15-28 (French).

van Binst, G.; Danheux, C. and Martin, R. H. "Studies of models of indole
alkaloids. IV. Solvent effect in infrared and NMR spectroscopy of methoxy
derivatives of 1,2,3,4-tetrahydrocarbazole.", Bulletin des Societes Chimiques
Belges, (1966), 75(3-4), 181-190.

van Binst, G.; Danheux, C.; Hootele, C.; Pecher, J. and Martin, R. H.
"Physicochemical studies of models of indole alkaloids. II. Nuclear magnetic
resonance of methoxytetrahydrocarbazoles.", Tetrahedron Letters, (1964), 17-18,
973-981 (French).

van Binst, G.; Denolin-Dewaersegger, L. and Martin, R. H. "Application of gas
phase chromatography to the study of products of pyrolysis of indole alkaloids.
I. Obtaining the pyrogram.", Journal of Chromatography (1964), 16(1), 34-39
(French).

Vincent, D. and Lagren, R. "Tonic drugs for muscle, defatiguing drugs and
cholinesterases.", Congres des Societes Savantes de Paris et des Departments,
Comptes Rendus, (1953), 563-569.

Vincent, D. and Lagreu, R. "The cholinesterase of the pancreas: its behavior
in presence of some inhibitors in comparison with the cholinesterases of serum
and brain.", Bulletin de la Societe de Chimie Biologique, (1949), 31, 1043-1045.

Vincent, D. and Beaujard, P. "Detection of cholinesterase-inhibiting
alkaloids (primarily eserine). Toxicological applications.", Annales
Pharmaceutiques Francaises, (1945), 3, 22-26.

Vincent, D. and Sero, I. "Inhibiting action of Tabernanthe iboga on serum
cholinesterase.", Comptes Rendus des Seances de la Societe de Biologie, (1942),
136, 612-614.

Vinson, J. A. and Hooyman, J. E. "Laboratory-use reagents. II. Universal
thin- layer chromatographic visualization reagents for drugs.", Journal of
Chromatography, (1975), 105(2), 415-417.

Vinson, J. A.; Hooyman, J. E. and Ward, C. E. "Identification of street drugs
by thin-layer chromatography and a single visualization reagent.", Journal of
Forensic Sciences, (1975), 20(3), 552-556.

Vocci, F. J. and London, E. D. "Assessment of neurotoxicity from potential
medications for drug abuse: ibogaine testing and brain imaging.", Annals of the
New York Academy of Sciences, (1997), 820, 29-40. PDF (919 KB)

Walaszek, E. J.; Huggins, C. G. and Smith, C. M. "Drugs that modify actions
of pharmacologically active polypeptides.", Annals of the New York Academy of
Sciences, (1963), 104(Article 1), 281-289.

Walls, F.; Collera, O. and L., Sandoval A. "Alkaloids from Stemmadenia
species-I. The alkaloids of S. Donnell-Smithii and S. Galleottiana.",
Tetrahedron, (1958), 2, 173-182. PDF (1.3 MB)

Warren, R. J.; Eisdorfer, I. B.; Thompson, W. E. and Zarembo, J. E. "Infrared
identification of indole ring in indoles and indole alkaloids in the 400- to
700- /cm region.", Journal of Pharmaceutical Sciences, (1965), 54(12),
1806-1807.

Warthen, John David Jr. "Synthesis of analogs of ibogaine.", Dissertation
Abstracts International. B, Science and Engineering., (1966), 27(4), 1107-1108.
PDF (460 KB)

Wenkert, Ernest; Cochran, David W.; Gottlieb, Hugo E. and Hagaman, Edward W.
"13C-NMR. Spectroscopy of naturally occurring substances. XLV. Iboga
alkaloids.", Helvetica Chimica Acta, (November 3, 1976), 59(7), 2437-2442. PDF (626 KB)

Whitaker, Patricia M. and Seeman, Philip. "Selective labeling of serotonin
receptors by d-[3H]-lysergic acid diethylamide in calf caudate.", Proceedings of
the National Academy of Sciences of the United States of America , (1978),
75(12), 5783-5387.

Whitaker, Patricia M. and Seeman, Philip. "High-affinity 3H-serotonin binding
to caudate: inhibition by hallucinogens and serotoninergic drugs.",
Psychopharmacology [Berlin], (1978), 59(1), 1-5.

Whitaker, Patricia M. and Seeman, Philip. "Hallucinogen binding to
dopamine/neuroleptic receptors.", Journal of Pharmacy and Pharmacology, (1977),
29(8), 506-507.

Witkin, J. M.; Brave, S.; French, D. and Geter-Douglass, B. "Discriminative
stimulus effects of R-(+)-3-amino-1-hydroxypyrrolid-2-one, [(+)-HA-966], a
partial agonist of the strychnine-insensitive modulatory site of the
N-methyl-D-aspartate receptor.", Journal of Pharmacology and Experimental
Therapeutics, (December 1995), 275(3), 1267-1273.

Woods, J. H.; France, C. P.; Medzihradsky, F.; Smith, C. B. and Winger, G. D.
"Evaluation of new compounds for opioid activity, 1992. [Review].", NIDA
Research Monograph, (1993), 132, 517-578.

Woods, J. H.; Medzihdsky, F.; Smith, C. B.; Winger, G. D. and Franc, C. P.
"1989 Annual report, evaluation of new compounds for opioid activity.", NIDA
Research Monographs, (1990), 95, 563,607,655-656.

Yamazaki, Mikio and Leete, Edward. "Biosynthesis of the iboga alkaloids.
Incorporation of tryptophan-3-14C into ibogaine.", Tetrahedron Letters, (1964),
23-24, 1499-1501.

Zetler, G. "Cholecystokinin octapeptide (CCK-8), ceruletide and analogues of
ceruletide: effects on tremors induced by oxotremorine, harmine and ibogaine. A
comparison with prolyl-leucylglycine amide (MIF), anti-Parkinsonian drugs and
clonazepam.", Neuropharmacology, (June 1983), 22(6), 757-766. PDF (1.3 MB)

Zetler, G.; Singbartl, G. and Schlosser, Lucie. "Cerebral pharmacokinetics of
tremor-producing harmala and iboga alkaloids.", Pharmacology, (1972), 7(4),
237-248. PDF (1.5 MB)

Zetler, Gerhard and Singbartl, G. "Inhibition of cardiac effects of
noradrenaline by eleven indole alkaloids, two azepinoindoles, quinidine,
quindonium, and propranolol.", Pharmacology, (1970), 4(3), 129-142.

Zetler, G.; Lenschow, E. and Prenger-Berninghoff, W. "[The actions of 11
indole-alkaloids on the guinea pig heart in vivo and in vitro, compared with
those of 2 synthetic azepinoindoles, quinidine and quindonium.]", Naunyn
Schmiedeberg's Archiv fur Pharmakologie und Experimentelle Pathologie, (1968),
260(1), 26-49 (German). PDF (4.3 MB)

Zetler, G. "[Some pharmacological properties of 12 natural and 11 partially
synthetic indole alkaloids from tropical Apocyanaceae of the sub-tribe
Tabernaemontaninae.]", Arzneimittel-Forschung, (1964), 14(12), 1277-1286
(German). PDF (1.9 MB)

Zetler, G.; Muller, W. and Warm, I. "Jactatio capitis, a pharmacologically
elicited stereotype motor reaction in the mouse.", Naunyn Schmiedeberg's Archiv
fur Pharmakologie und Experimentelle Pathologie, (1959), 237, 247-263.

Zetler, G. and Unna, K. R. "Central effects of voacangine, voacamine,
voacamidine, voacorine, and ibogaine.", Naunyn Schmiedeberg's Archiv fur
Pharmakologie und Experimentelle Pathologie, (1959), 236, 122-123. PDF (655 KB)